Alan M Palmer
Neuroscience
Cerebral Therapeutics
United Kingdom
Biography
Alan M Palmer has formed or co-founded six biotech start-up companies. He is presently a Board director of Cerebroscience Ltd, MS Therapeutics Ltd, One Nucleus, Neuro 360 Ltd and the British Neuroscience Association. With over 100 peer-reviewed papers to his name, his scientific research has had a high impact, particularly in the study of Alzheimer’s disease and traumatic brain injury. He is Visiting Professor at University College London and the University of Reading and Life Science Entrepreneur in Residence at the University of Bristol. He was voted London Biotechnology Network Entrepreneur of the Year in 2005. Alan M Palmer has formed or co-founded six biotech start-up companies. He is presently a Board director of Cerebroscience Ltd, MS Therapeutics Ltd, One Nucleus, Neuro 360 Ltd and the British Neuroscience Association. With over 100 peer-reviewed papers to his name, his scientific research has had a high impact, particularly in the study of Alzheimer’s disease and traumatic brain injury. He is Visiting Professor at University College London and the University of Reading and Life Science Entrepreneur in Residence at the University of Bristol. He was voted London Biotechnology Network Entrepreneur of the Year in 2005.
Research Interest
dementia
